多器官联合移植
- 网络combined multiple organs transplantation
-
1例腹腔多器官联合移植病人的手术配合
Experience of nursing coordination of a case undergoing combined multiple organs transplantation of abdominal cavity
-
结论多器官联合移植术后采用ATG、抗CD25单克隆抗体诱导,FK506、MMF及激素三联维持治疗是安全有效的,用药期间应监测移植物功能和FK506的血药浓度,防止排斥反应和FK506中毒。
Conclusion Induction therapy with ATG and anti-CD25 monoclonal antibody and maintaining therapy including FK506 , MMF and steroids after multiple organ transplantation are safe and effective . Monitoring of graft function and FK506 level is important for avoiding the rejection and nephrotoxicity caused by FK506 .
-
目的探讨多器官联合移植术后的免疫抑制治疗方法。
Objective To study immunosuppressive therapy after multiple organ transplantation .
-
腹部多器官联合移植的基础与临床研究
Basic and Clinical Study of Abdominal Multiorgan Combined Transplantation
-
猪腹部多器官联合移植术中血流动力学变化及处理
Hemodynamic changes and corresponding protective measures after orthotopic abdominal multivisceral transplantation in pigs
-
临床腹部多器官联合移植术中血液生化的改变
Biochemical changes during the clinical abdominal multivisceral transplantation
-
多器官联合移植的免疫抑制治疗
Immunosuppressive therapy after multiple organ transplantation
-
腹部多器官联合移植研究进展
Advances of Abdominal Multivisceral Transplantation
-
方法我院自2001年10月至2005年1月共施行19例腹部多器官联合移植术,其中胰肾联合移植6例、肝肾联合移植12例、肝胰联合移植1例;
Methods From October 2001 to January 2005 , 19 patients received multiorgan transplantation in Nanfang Hospital , including 6 with simultaneous kidney-pancreas transplantation ( SKPT ), 12 with combined liver-kidney transplantation ( CLKT ), and 1 with simultaneous liver-pancreas transplantation ( SLPT ) .